In Interventional Pain Practices across the country, Advanced Practice Providers (APPs) are key players—trusted by patients and vital to the effective, efficient flow of a busy pain practice. Moreover, when it comes to bringing lumbar spinal stenosis (LSS) patients the benefits of mild®, APPs are increasingly taking a leading role—guiding the patient from initial diagnosis, performing MRI/imaging reviews, educating patients about what to expect, scheduling procedures, and assessing the results at follow up.
We see you.
We recognize all the APPs do to help LSS patients find relief. With this shared goal in mind, we began asking APPs, “What can we do to help you in your day-to-day role?” and “How can we be the best possible partner to you over time?”
We hear you.
We spoke to dozens of APPs, and several themes came through loud and clear. We hear that you want to have a stronger voice in the Interventional Pain Community, to take on more leadership within your own practices or community, and to have easier access to training and support.
We’re with you.
That’s why we created the Vertos APP Advisory Board—a committee of dedicated professionals at all stages of their careers and with a wide spectrum of credentials who are excited to help harness more resources, support, and recognition for APPs. The goals of the Advisory Board are to:
Engage and empower every APP in the Interventional Pain community through training, recognition, collaboration, and peer-to-peer support
Help more patients gain access to the mild® Procedure by optimizing LSS identification, treatment planning, practice workflows, and patient recovery in every practice
The Vertos APP Advisory Board
Kristen Bowman, NP Nevada Advanced Pain Specialists, Reno, NV 5 Years in IPM
Christine Christensen, NP Spine and Pain Institute of Florida, Lakeland, FL 1 Year in IPM
Ashley Comer, NP Spine and Nerve Centers, Charleston, WV 7 Years in IPM
Lauren Cote, APRN Ascension Kansas, Wichita, KS 3 Years in IPM
Tiffany Doyle, APN NorthShore University HealthSystem, Skokie, IL 2 Years in IPM
Jane Hartigan, PA Evolve Restorative Center, Santa Rosa, CA 2 Years in IPM
Zohra Hussaini, NP University of Kansas Health System Academic Medical Center, Kansas City, KS 10 Years in IPM
Amanda Hyland, PA-C Pennsylvania Pain and Spine Institute, Chalfont, PA 4 Years in IPM
Kelsey Kimball, PA The Orthopaedic Institute, Gainesville, FL 1 Year in IPM
Kristen Klein, NP Pain Institute of Long Island, Long Island, NY 3.5 Years in IPM
Russell Little, NP Relievus, Vineland, NJ 6 Years in IPM
James Lynch, PA Pain Consultants of San Diego, San Diego, CA 1 Year in IPM
Patrick McGinn, PA Premier Pain Centers, Shrewsbury, NJ 5.5 Years in IPM
Lauren Williams, PA-C FirstHealth/Pinehurst Anesthesia Associates, Pinehurst, NC 1.5 Years in IPM
Marie Zambelli, MSN FNP-C Restore Medical Partners, Venice, FL 2.5 Years in IPM
Interested in APP focused education and events? Sign up to stay informed and receive the latest updates!
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary at knowyourbackstory.com.